Founded in 2011 by Dr. Raymond Glocker, emka medical aims to provide patients with cardiopulmonary diseases the best possible hemodynamic monitoring during their treatment. With over 30 years of experience in the medical device industry, Dr.

Glocker recognized the need for a more stable and continuous invasive blood pressure measurement for heart failure monitoring. As a result, emka medical developed the first closed fluid-filled catheter, called CorLog, which offers direct and continuous feedback on core parameters like pressure inside the heart. This data-driven therapy approach enables the optimization of medication or device-based therapy for better patient outcomes.

Additionally, emka medical strives to enhance patients' quality of life by reducing restrictions such as tubings and cables, allowing for greater mobility. To ensure the highest quality and safety standards, emka medical is certified according to EU-MDD (93/42/EEC) and ISO 13485:2016